102 related articles for article (PubMed ID: 2580024)
1. A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen.
Forman SJ; Zaia JA; Clark BR; Wright CL; Mills BJ; Pottathil R; Racklin BC; Gallagher MT; Welte K; Blume KG
J Immunol; 1985 May; 134(5):3391-5. PubMed ID: 2580024
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
3. Predictable alphabeta T-cell receptor selection toward an HLA-B*3501-restricted human cytomegalovirus epitope.
Brennan RM; Miles JJ; Silins SL; Bell MJ; Burrows JM; Burrows SR
J Virol; 2007 Jul; 81(13):7269-73. PubMed ID: 17459926
[TBL] [Abstract][Full Text] [Related]
4. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations.
Kumar P; Uchil PD; Sulochana P; Nirmala G; Chandrashekar R; Haridattatreya M; Satchidanandam V
Arch Virol; 2003 Aug; 148(8):1569-91. PubMed ID: 12898332
[TBL] [Abstract][Full Text] [Related]
5. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
Ihle JN; Lee JC; Rebar L
J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus matrix protein PP150 is efficiently presented as one of target antigens for cytotoxic T lymphocyte recognition.
Li C; Yang X; Tu W; Riddell SR
Chin Med J (Engl); 1997 May; 110(5):397-400. PubMed ID: 9594311
[TBL] [Abstract][Full Text] [Related]
8. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
Maecker HT; Maino VC
Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
[TBL] [Abstract][Full Text] [Related]
9. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
Davies JK; Koh MB; Lowdell MW
Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
Rölle A; Olweus J
APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
[TBL] [Abstract][Full Text] [Related]
11. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
12. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
13. General characterization of human cytomegalovirus-specific proliferative CD4+ T cell clones.
Liu YN; Eckhardt J; Kari B; Gehrz RC
Int J Cell Cloning; 1988 Sep; 6(5):352-64. PubMed ID: 2846712
[TBL] [Abstract][Full Text] [Related]
14. Human antibody response to human cytomegalovirus-specific DNA-binding proteins.
Gergely L; Czeglédy J; Váczi L
Acta Virol; 1988 Jan; 32(1):1-5. PubMed ID: 2897767
[TBL] [Abstract][Full Text] [Related]
15. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection.
Selgrade MK; Huang YS; Graham JA; Huang CH; Hu PC
J Immunol; 1983 Dec; 131(6):3032-5. PubMed ID: 6315823
[TBL] [Abstract][Full Text] [Related]
16. Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin A; Xu H; Yan W
Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
[TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display.
Beghetto E; Paolis FD; Spadoni A; Del Porto P; Buffolano W; Gargano N
J Virol Methods; 2008 Jul; 151(1):7-14. PubMed ID: 18499273
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus (CMV)-specific cellular immune responses.
Harari A; Zimmerli SC; Pantaleo G
Hum Immunol; 2004 May; 65(5):500-6. PubMed ID: 15172450
[TBL] [Abstract][Full Text] [Related]
19. Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.
Williamson SA; Parish N; Chambers JD; Knight RA
Immunology; 1986 Mar; 57(3):437-42. PubMed ID: 3007334
[TBL] [Abstract][Full Text] [Related]
20. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
Reddehase MJ; Keil GM; Koszinowski UH
J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
